Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cornel

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Molecular Therapy. Methods & Clinical Development|April 26, 2021
Efficient lentiviral transduction method to gene modify cord blood CD8<sup>+</sup> T cells for cancer therapy applicationsVania Lo Presti, Annelisa M Cornel, Maud Plantinga, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 1, 1993
Zinc supplementation in very-low-birth-weight infantsJ K Friel, W L Andrews, J D Matthew, et al.
Teratology|November 1, 1991
Heterogeneity of neural tube defects in Europe: the significance of site of defect and presence of other major anomalies in relation to geographic differences in prevalenceH Dolk, P De Wals, Y Gillerot, et al.
The CRISPR Journal|June 10, 2022
Gene Editing of Checkpoint Molecules in Cord Blood-Derived Dendritic Cells and CD8<sup>+</sup> T Cells Using CRISPR-Cas9Vania Lo Presti, Alessandro Cutilli, Yvonne Dogariu, et al.
Journal of Epidemiology and Community Health|January 5, 2000
Time trends in neural tube defects prevalence in relation to preventive strategies: an international studyA Rosano, D Smithells, L Cacciani, et al.
The Journal of Clinical Investigation|November 25, 2025
CAR-T-cells targeting the glycoprotein GD2 show potent anti-tumor efficacy in high-risk ependymoma modelsAntonio Carlos Tallon-Cobos, Konstantinos Vazaios, Piotr Waranecki, et al.
Haematologica|August 8, 2024
Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemiaFarnaz Barneh, Joost B Koedijk, Noa E Wijnen, et al.
Journal of Personalized Medicine|September 28, 2021
αβ-T Cells Engineered to Express γδ-T Cell Receptors Can Kill Neuroblastoma Organoids Independent of MHC-I ExpressionJosephine G M Strijker, Ronja Pscheid, Esther Drent, et al.
Molecular Therapy. Oncology|May 8, 2026
Boosting CAR T cell functionality with oncolytic viruses for the treatment of pediatric diffuse midline gliomasKonstantinos Vazaios, Antonio C Tallon-Cobos, Louisa P J van Oosterhout, et al.
Nature Protocols|March 20, 2024
BEHAV3D: a 3D live imaging platform for comprehensive analysis of engineered T cell behavior and tumor responseMaria Alieva, Mario Barrera Román, Sam de Blank, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Molecular Therapy. Methods & Clinical Development|April 26, 2021
Efficient lentiviral transduction method to gene modify cord blood CD8<sup>+</sup> T cells for cancer therapy applicationsVania Lo Presti, Annelisa M Cornel, Maud Plantinga, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 1, 1993
Zinc supplementation in very-low-birth-weight infantsJ K Friel, W L Andrews, J D Matthew, et al.
Teratology|November 1, 1991
Heterogeneity of neural tube defects in Europe: the significance of site of defect and presence of other major anomalies in relation to geographic differences in prevalenceH Dolk, P De Wals, Y Gillerot, et al.
The CRISPR Journal|June 10, 2022
Gene Editing of Checkpoint Molecules in Cord Blood-Derived Dendritic Cells and CD8<sup>+</sup> T Cells Using CRISPR-Cas9Vania Lo Presti, Alessandro Cutilli, Yvonne Dogariu, et al.
Journal of Epidemiology and Community Health|January 5, 2000
Time trends in neural tube defects prevalence in relation to preventive strategies: an international studyA Rosano, D Smithells, L Cacciani, et al.
The Journal of Clinical Investigation|November 25, 2025
CAR-T-cells targeting the glycoprotein GD2 show potent anti-tumor efficacy in high-risk ependymoma modelsAntonio Carlos Tallon-Cobos, Konstantinos Vazaios, Piotr Waranecki, et al.
Haematologica|August 8, 2024
Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemiaFarnaz Barneh, Joost B Koedijk, Noa E Wijnen, et al.
Journal of Personalized Medicine|September 28, 2021
αβ-T Cells Engineered to Express γδ-T Cell Receptors Can Kill Neuroblastoma Organoids Independent of MHC-I ExpressionJosephine G M Strijker, Ronja Pscheid, Esther Drent, et al.
Molecular Therapy. Oncology|May 8, 2026
Boosting CAR T cell functionality with oncolytic viruses for the treatment of pediatric diffuse midline gliomasKonstantinos Vazaios, Antonio C Tallon-Cobos, Louisa P J van Oosterhout, et al.
Nature Protocols|March 20, 2024
BEHAV3D: a 3D live imaging platform for comprehensive analysis of engineered T cell behavior and tumor responseMaria Alieva, Mario Barrera Román, Sam de Blank, et al.
Pageof 7